CN108030527A - A kind of staple for stapler - Google Patents
A kind of staple for stapler Download PDFInfo
- Publication number
- CN108030527A CN108030527A CN201810104468.3A CN201810104468A CN108030527A CN 108030527 A CN108030527 A CN 108030527A CN 201810104468 A CN201810104468 A CN 201810104468A CN 108030527 A CN108030527 A CN 108030527A
- Authority
- CN
- China
- Prior art keywords
- staple
- stapler
- passage
- section
- cross
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 10
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 5
- 229960003500 triclosan Drugs 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 4
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 claims description 3
- 229910000861 Mg alloy Inorganic materials 0.000 claims description 3
- 229920002413 Polyhexanide Polymers 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 3
- -1 acyloxy diphenyl ether Chemical compound 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Natural products C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims description 3
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 claims description 3
- 229910052733 gallium Inorganic materials 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052737 gold Inorganic materials 0.000 claims description 3
- 239000010931 gold Substances 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- IFYDWYVPVAMGRO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)NCCCN(C)C IFYDWYVPVAMGRO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 229910052715 tantalum Inorganic materials 0.000 claims description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 3
- 229910052719 titanium Inorganic materials 0.000 claims description 3
- 239000010936 titanium Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- AJKIRUJIDFJUKJ-UHFFFAOYSA-N taurolidine Chemical compound C1NS(=O)(=O)CCN1CN1CNS(=O)(=O)CC1 AJKIRUJIDFJUKJ-UHFFFAOYSA-N 0.000 claims description 2
- 229960004267 taurolidine Drugs 0.000 claims description 2
- 206010067268 Post procedural infection Diseases 0.000 abstract description 4
- 206010051077 Post procedural haemorrhage Diseases 0.000 abstract description 3
- 208000037486 Postoperative Hemorrhage Diseases 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 238000010586 diagram Methods 0.000 description 7
- 238000005452 bending Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000009527 percussion Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 206010050456 Anastomotic leak Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 229940048368 flamazine Drugs 0.000 description 1
- 238000011902 gastrointestinal surgery Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229960001774 octenidine Drugs 0.000 description 1
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
- A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
- A61B17/07207—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously the staples being applied sequentially
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B17/0644—Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention discloses a kind of staple for stapler, inside includes more than 1 hollow channel.The passage is completely contained in the staple in an initial condition, and during the staple compressive deformation, the passage is communicated with the external world.The staple and the cross section of the passage are at least one to be non-circular.Contain antimicrobial in passage.Staple formation stability can be improved, and reduces the risk of postoperative hemorrhage and infection.
Description
Technical field
The present invention relates to surgical operating instrument technical field, more particularly to a kind of staple for stapler.
Background technology
With the development and research and development of products of medicine, stapler is widely used in gastrointestinal surgery, liver and gall surgical department, thoracic surgery, secretes
The every field such as surgery, gynemetrics are urinated, become one of essential instrument of doctor.
The operation principle of stapler is identical with stapler, i.e., the multiple rows of staple to intermesh of percussion implantation is to group into tissue
Knit and carry out multiple rows of intersection stapling, suture is tight, prevents from leaking.The staple of original state, substantially U-shaped, stapler closure percussion
When, staple promotes piercing to be sewn tissue by pushing slice of nail, and B shapes are then inwardly closed under resist-nailed seat effect, and fixation is sewn
Tissue, realizes engaging tissue.Since thin vessels can be from the gap of " B " shape staple by therefore not influencing suturing part and its remote
The blood supply at end.Compared with manual suture line, stitching speed is fast, reduces patient's pain.Due to staple marshalling, spacing phase
Deng suture elasticity is controlled by scale, and avoiding manual suture, to dredge overstocked and ligation tension excessively excessively loose, therefore ensure that tissue is good
Good healing.
Currently used staple cross section is circle, in stapler closes staple forming process, for being subject to tissue to lead
The external force effect such as draw, staple easily twists and misplaces, thus can not good closure be sewn tissue, and then trigger previous anastomotic
The complication such as fistula.
The content of the invention
The technical problem to be solved in the present invention is to provide the staple for stapler of a kind of anti-torsion and dislocation, so that gram
The deficiency of existing staple is taken, improves staple formation stability, and reduce the risk of postoperative hemorrhage and infection.
The technical solution adopted by the present invention to solve the technical problems is：A kind of staple for stapler, inside include 1
A above hollow channel.
The passage is completely contained in the staple in an initial condition, during the staple compressive deformation, the passage
Communicated with the external world.
The staple and the cross section of the passage are at least one to be non-circular.
The staple and/or the channel cross-section are more than along the staple length side along staple width distance
To distance.
Preferably, the staple cross section includes circle, ellipse, triangle, quadrangle.
Preferably, the channel cross-section includes circle, ellipse, triangle, quadrangle.
Contain antimicrobial in the passage.
Preferably, the antimicrobial includes hydroxy ether, acyloxy diphenyl ether and the combinations thereof of halo.
Preferably, the antimicrobial is selected from Octenidine, PHMB, triclosan, copper, silver, gold, selenium, gallium, ox sulphur sieve
Fixed, 2- (chloro amido) ethyl sulfonic acid, alcohol, LAE, MAPD, OAPD and their mixture.
The staple material is selected from titanium, tantalum, magnesium alloy.
The beneficial effects of the invention are as follows：The present invention is used for the staple of stapler, using noncircular cross section and/or passage, leads to
Cross in staple stress BENDING PROCESS, the yield strength of bending position it is expected using own form to reduce staple, so that seam
Nail is more easy to deform in desired position, and is not easy to twist, and then realizes good " B " font forming effect, reduces
The generation of anastomotic leakage complication.At the same time by injecting antimicrobial into tissue, the possibility of postoperative hemorrhage and infection is reduced.
Brief description of the drawings
Above-mentioned is only the general introduction of technical solution of the present invention, in order to better understand the technological means of the present invention, below
With reference to attached drawing, the present invention is described in further detail with embodiment.
Fig. 1 is the staple diagrammatic cross-section that the present invention is used for stapler.
Fig. 2 is the schematic diagram after the present invention is extruded for the staple of stapler.
Fig. 3 is a kind of embodiment schematic diagram for the staple that the present invention is used for stapler.
Fig. 4 is second of embodiment schematic diagram of the staple that the present invention is used for stapler.
Fig. 5 is the third embodiment schematic diagram for the staple that the present invention is used for stapler.
Fig. 6 is the 4th kind of embodiment schematic diagram of the staple that the present invention is used for stapler.
Fig. 7 is the 5th kind of embodiment schematic diagram of the staple that the present invention is used for stapler.
Fig. 8 is the 6th kind of embodiment schematic diagram of the staple that the present invention is used for stapler.
Description of reference numerals：1- staples, 2- passages, 3- antimicrobials, 4- are stapled tissue.
Embodiment
The present invention provides a kind of staple for stapler, in order to make those skilled in the art more fully understand the present invention
Technical solution, below in conjunction with the drawings and specific embodiments, the present invention is described in further detail.
【Embodiment 1】
Referring to the drawings shown in 1 to 3, according to an embodiment of the invention, the inside of staple 1 for stapler includes 2 hollow channels
2.Passage 2 is completely contained in staple 1 in an initial condition；After stapler, which closes, to be fired, 1 compressive deformation of staple, nail leg end
End section is broken, and passage 2 is communicated with the external world at this time.
1 cross section of staple is semicircle, and its outer surface is plane.2 cross section of passage is circle.Due to 1 section of staple
Width distance is more than length direction distance.Therefore when nail leg is pressurized, staple 1 reaches up to bending resistance in relatively thin side first
Ultimate strength simultaneously curves inwardly, and is then not susceptible to deform on thicker direction, therefore prevents the torsiversion malposition of staple, ensures
The B fonts that staple 1 is formed are in the plane.
The antimicrobial 3 contained in passage 2 is triclosan or flamazine or nano silver or sulphadiazine.Resist micro- life
Agent 3 can also include hydroxy ether, acyloxy diphenyl ether and the combinations thereof of halo.Antimicrobial 3 is further selected from Austria and replaces
Buddhist nun's pyridine, PHMB, triclosan, copper, silver, gold, selenium, gallium, Taurolidine, 2- (chloro amido) ethyl sulfonic acid, alcohol, LAE, MAPD, OAPD with
And their mixture.When 1 compressive deformation of staple, nail leg tip breakages, the extruding injection of staple 1 that triclosan is deformed is kissed
It is combined and knits in 4, so as to reduces the possibility of postoperative infection.
1 material of staple is titanium, tantalum, magnesium alloy.
【Embodiment 2】
Referring to the drawings shown in 4, except 1 cross section of staple is circle, 2 cross section of passage for outside rectangle, the embodiment with【Embodiment
1】It is identical.
【Embodiment 3】
Referring to the drawings shown in 5, except 1 cross section of staple is circle, 2 cross section of passage to be semicircle outer, the embodiment with【Embodiment
1】It is identical.
【Embodiment 4】
Referring to the drawings shown in 6, except 1 cross section of staple be rectangle, 2 cross section of passage to be circular outer, the embodiment and【Embodiment
1】It is identical.
【Embodiment 5】
Referring to the drawings shown in 7, except 1 cross section of staple be rectangle, 2 cross section of passage for outside rectangle, the embodiment and【Implement
Example 1】It is identical.
【Embodiment 6】
Referring to the drawings shown in 8, except 1 cross section of staple be it is trapezoidal, 2 cross section of passage to be circular outer, the embodiment with【Embodiment 1】
It is identical.
The staple provided by the present invention for stapler is described in detail above.It is used herein specifically to show
Example is set forth the principle of the present invention and embodiment, but the explanation of above example is only intended to help to understand the present invention
Principle and its core concept, not limiting the scope of the present invention.It should be pointed out that the common skill for the art
For art personnel, without departing from the principle of the present invention, some improvement and modification can also be carried out to the present invention, these change
Also fallen into modification in the protection domain of the claims in the present invention.
Claims (10)
- A kind of 1. staple for stapler, it is characterized in that internal include more than 1 hollow channel.
- 2. the staple according to claim 1 for stapler, it is characterised in that the passage is complete in an initial condition In the staple, during the staple compressive deformation, the passage is communicated with the external world.
- 3. the staple according to claim 2 for stapler, it is characterised in that the staple is transversal with the passage Face is at least one to be non-circular.
- 4. the staple according to claim 3 for stapler, it is characterised in that the staple and/or the passage are horizontal Section is more than along the staple length direction distance along staple width distance.
- 5. the staple according to claim 4 for stapler, it is characterised in that the staple cross section include it is circular, Ellipse, triangle, quadrangle.
- 6. the staple according to claim 4 for stapler, it is characterised in that the channel cross-section include it is circular, Ellipse, triangle, quadrangle.
- 7. the staple according to claim 1 for stapler, it is characterised in that containing antimicrobial in the passage Agent.
- 8. the staple according to claim 7 for stapler, it is characterised in that the antimicrobial includes halo Hydroxy ether, acyloxy diphenyl ether and combinations thereof.
- 9. the staple according to claim 7 for stapler, it is characterised in that the antimicrobial is selected from Austria and replaces Buddhist nun Pyridine, PHMB, triclosan, copper, silver, gold, selenium, gallium, Taurolidine, 2- (chloro amido) ethyl sulfonic acid, alcohol, LAE, MAPD, OAPD and Their mixture.
- 10. the staple according to claim 1 for stapler, it is characterised in that the staple material be selected from titanium, tantalum, Magnesium alloy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810104468.3A CN108030527A (en) | 2018-02-02 | 2018-02-02 | A kind of staple for stapler |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810104468.3A CN108030527A (en) | 2018-02-02 | 2018-02-02 | A kind of staple for stapler |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108030527A true CN108030527A (en) | 2018-05-15 |
Family
ID=62097170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810104468.3A Pending CN108030527A (en) | 2018-02-02 | 2018-02-02 | A kind of staple for stapler |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108030527A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040006372A1 (en) * | 2000-10-20 | 2004-01-08 | Racenet David C. | Directionally biased staple and method of manufacturing |
| CN101933824A (en) * | 2009-06-29 | 2011-01-05 | Tyco医疗健康集团 | Self-sealing compositions |
| CN103987328A (en) * | 2011-09-15 | 2014-08-13 | 伊西康内外科公司 | Surgical instrument with filled staple |
| CN104922737A (en) * | 2015-06-12 | 2015-09-23 | 珠海拓爱医疗科技有限公司 | Memory alloy skin tissue suturing nail |
| CN204766707U (en) * | 2015-06-12 | 2015-11-18 | 珠海拓爱医疗科技有限公司 | Nail is sewed up to memory alloy skin tissue |
| CN205041835U (en) * | 2015-06-18 | 2016-02-24 | 赵宇 | Nail is sewed up to degradable for anastomat |
| CN209032485U (en) * | 2018-02-02 | 2019-06-28 | 派尔特（苏州）医疗科技有限公司 | A kind of staple for stapler |
-
2018
- 2018-02-02 CN CN201810104468.3A patent/CN108030527A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040006372A1 (en) * | 2000-10-20 | 2004-01-08 | Racenet David C. | Directionally biased staple and method of manufacturing |
| CN101933824A (en) * | 2009-06-29 | 2011-01-05 | Tyco医疗健康集团 | Self-sealing compositions |
| CN103987328A (en) * | 2011-09-15 | 2014-08-13 | 伊西康内外科公司 | Surgical instrument with filled staple |
| CN104922737A (en) * | 2015-06-12 | 2015-09-23 | 珠海拓爱医疗科技有限公司 | Memory alloy skin tissue suturing nail |
| CN204766707U (en) * | 2015-06-12 | 2015-11-18 | 珠海拓爱医疗科技有限公司 | Nail is sewed up to memory alloy skin tissue |
| CN205041835U (en) * | 2015-06-18 | 2016-02-24 | 赵宇 | Nail is sewed up to degradable for anastomat |
| CN209032485U (en) * | 2018-02-02 | 2019-06-28 | 派尔特（苏州）医疗科技有限公司 | A kind of staple for stapler |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104507398B (en) | Fastener, configuration system and method for ocular tissue's closure, the fixation of eye prosthese and other purposes | |
| CN103747746B (en) | Drug-eluting self-retaining sutures and methods relating thereto | |
| EP1726317A1 (en) | Surgical thread and cosmetic surgery method | |
| MX2010011160A (en) | Self-retaining sutures with bi-directional retainers or uni-directional retainers. | |
| BR112013024303B1 (en) | SELF-RETENTION SUTURE SYSTEM AND METHOD FOR MANUFACTURING A SELF-RETENTION SUTURE SYSTEM | |
| CN101902974A (en) | Have by heat-contact mediated retainers from straight suture | |
| US20110144666A1 (en) | Surgical apparatus | |
| RU2649965C1 (en) | Method for elimination of ptosis of soft tissues of the face | |
| CN209032485U (en) | A kind of staple for stapler | |
| CN108030527A (en) | A kind of staple for stapler | |
| CN203591289U (en) | In-vivo absorbable metal closing nail of three-dimensional structure | |
| CN103271750B (en) | Hernical sac neck high ligation operating theater instruments and operation method | |
| CN215273032U (en) | Medical anchor with wire | |
| CN104116535A (en) | Suture line with reverse threads | |
| CN202223282U (en) | Surgical suturing device | |
| CN210990479U (en) | Suture and surgical suturing device | |
| CN106798585A (en) | A kind of Median sternotomy incision suture fixation bandage | |
| CN210204810U (en) | Bifilar surgical suture needle | |
| CN209678592U (en) | A kind of circular staplers with 3D nail slot structure resist-nailed seat | |
| CN209107445U (en) | A kind of Medical absorbable synthesis suture | |
| WO2019169901A1 (en) | Tendon anti-adhesion membrane for strengthening tendon anastomosis | |
| CN104822347B (en) | Fastener, configuration system and method for ocular tissue's closure, the fixation of eye prosthese and other purposes | |
| CN103519857A (en) | Absorbable metal closing nail in body and of three-dimensional structure and forming method thereof | |
| CN102160810A (en) | Surgical stapler | |
| RU2009105136A (en) | LIGATURAL LOCKING DEVICE FOR SEWING OF THE SKIN SECTION AND / OR BODY TISSUE AND WITHOUT KNITTING METHOD FOR SEWING A SKIN AND / OR BODY TISSUE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |